Difference between revisions of "MDMA"
From The SpiritWiki
| Line 11: | Line 11: | ||
MDMA is a "breakthrough" therapy for PTSD.<ref>Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.</ref> | MDMA is a "breakthrough" therapy for PTSD.<ref>Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.</ref> | ||
==Effects== | |||
* [https://twitter.com/hilaryagro/status/1229177598003077123?s=46&t=dCwTLAOT1xQPTMd3Z7VoXg MDMA and libertarianism] | |||
{{endstuff}} | {{endstuff}} | ||
Revision as of 13:48, 16 September 2022
MDMA is an extremely powerful Entactogen that temporarily suppresses the body's fear and anxiety response thus enabling one to recognize and process even deeply buried traumatic experiences.
List of Connection Supplements
Connection Supplement > 5-MEO DMT, Ayahuasca, Cannabis, Chloroform, DMT, Datura, Haoma, Kaneh Bosm, Kava, Ketamine, Kykeon, LSD, MDMA, Maikua, Manna, Nitrous Oxide, Peyote, Psilocybin Mushroom, Santa Rosa, Soma, Tobacco, Yaqona
Notes
MDMA is not a recreational drug and should not be used as such. MDMA is a powerful psychoactive that is extremely useful for healing even deep trauma.
MDMA is a "breakthrough" therapy for PTSD.[1]
Effects
Footnotes
- ↑ Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.
